Table 1.
Type of cancer | CXCL9 Expression | Source | Sample Number | Prognosisa | Ref |
---|---|---|---|---|---|
NSCLC | Low | Tumor cells | 109 | No relation | 38 |
High | Tumor cells | 12 | Might be good | 37 | |
High | Tumor cells | 90 | Good | 36 | |
Breast cancer | High | Tumor cells | 60 | Good | 42 |
High | Tumor cells | 1058 | Good | 43 | |
CTCL | High (early), low (advanced) | Tumor cells | 9 (early), 13 (advanced) | Might be good | 49 |
High | Tumor cells | 11 | Might be good | 48 | |
Colorectal cancer | Low | Tumor cells | 196 | Poor | 55 |
High | Tumor cells | 130 | Good | 54 | |
UC‐Ca | High | Serum | 10 | Might be good | 56 |
Melanoma | High | Tumor cells | 113 | Might be good | 60 |
High | Tumor cells | 44 | Might be good | 61 | |
Ovarian cancer | High | TCs, macrophages | 85 | Might be good | 66 |
GC(lymphocyte‐rich) | High | stromal cells, a few TCs | 42 | Might be good | 68 |
GC | High | mononuclear cells | 22 | Might be good | 69 |
Ewing sarcoma | High | tumor and stromal cells | 20 | No relation | 70 |
Cutaneous tumor | High | Tumor cells | 42 | Might be good | 71 |
NSCLC, Non‐small‐cell lung cancer; CTCL, Cutaneous T‐cell lymphoma; UC‐Ca, ulcerative colitis‐associated cancer; RCC, Renal cell carcinoma; TCs, Tumor cells; GC, Gastric carcinoma.
The response as “Good” means good prognosis of cancer patients, good response to tumor therapy, or reduction of tumor burden.